Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezepelumab on Airway Structure and Function in Uncontrolled Moderate-to-severe Asthma
NCT05280418Phase 3Completed
- Sponsor
- McMaster University
- Start
- Nov 2022
- Primary completion
- Nov 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of tezepelumab in asthma, sponsored by McMaster University. Started Nov 2022; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05280418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05280418.